Učitavanje...

Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

Purpose: Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Márcio Debiasi, Tomás Reinert, Rafael Kaliks, Gilberto Amorim, Maira Caleffi, Carlos Sampaio, Gustavo dos Santos Fernandes, Carlos H. Barrios
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2017-06-01
Serija:Journal of Global Oncology
Online pristup:http://ascopubs.org/doi/10.1200/JGO.2016.005678
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!